ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesD23.1

D23.1

Billable

Other benign neoplasm of skin of eyelid, including canthus

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 D23.1 is a billable code used to indicate a diagnosis of other benign neoplasm of skin of eyelid, including canthus.

Key Diagnostic Point:

D23.1 refers to benign neoplasms of the skin located specifically on the eyelid, including the canthus, which is the corner of the eye where the upper and lower eyelids meet. These neoplasms can present as various types of growths, such as seborrheic keratosis, dermatofibromas, or other benign tumors. Clinically, these lesions are typically asymptomatic but may cause cosmetic concerns or irritation. Diagnosis is usually made through clinical examination, and in some cases, a biopsy may be performed to confirm the benign nature of the lesion. Management often involves monitoring for changes, and surgical excision may be indicated if the lesion is symptomatic or for cosmetic reasons. Follow-up care is essential to ensure that the lesion does not recur or change in character, which could necessitate further intervention.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Differentiating between benign and malignant lesions
  • Need for precise documentation of lesion characteristics
  • Potential for multiple lesions requiring coding
  • Variability in clinical presentation

Audit Risk Factors

  • Inadequate documentation of lesion characteristics
  • Failure to specify the exact location of the neoplasm
  • Misclassification of benign lesions as malignant
  • Lack of follow-up documentation

Specialty Focus

Medical Specialties

Ophthalmology

Documentation Requirements

Detailed descriptions of the lesion, including size, color, and any symptoms.

Common Clinical Scenarios

Evaluation of eyelid lesions during routine eye exams or referrals for cosmetic concerns.

Billing Considerations

Ensure that the documentation reflects the benign nature of the lesion and any treatment provided.

Dermatology

Documentation Requirements

Comprehensive notes on the lesion's appearance, history, and any treatments performed.

Common Clinical Scenarios

Management of skin lesions on the eyelid, including biopsies and excisions.

Billing Considerations

Documentation should include the rationale for any surgical interventions and follow-up plans.

Coding Guidelines

Inclusion Criteria

Use D23.1 When
  • According to ICD
  • 10 coding guidelines, D23
  • 1 should be used when the neoplasm is confirmed as benign and located specifically on the eyelid

Exclusion Criteria

Do NOT use D23.1 When
  • Exclusion criteria include malignant neoplasms or lesions not located on the eyelid

Related ICD-10 Codes

Related CPT Codes

11400CPT Code

Excision, benign lesion

Clinical Scenario

Used when excising a benign eyelid lesion coded as D23.1.

Documentation Requirements

Document the size, location, and type of lesion excised.

Specialty Considerations

Ophthalmologists and dermatologists should ensure accurate coding based on the procedure performed.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of benign neoplasms, improving the accuracy of data collection and reimbursement processes. D23.1 provides a clear distinction from malignant codes, which is crucial for patient management and treatment planning.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of benign neoplasms, improving the accuracy of data collection and reimbursement processes. D23.1 provides a clear distinction from malignant codes, which is crucial for patient management and treatment planning.

Reimbursement & Billing Impact

reimbursement processes. D23.1 provides a clear distinction from malignant codes, which is crucial for patient management and treatment planning.

Resources

Clinical References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Coding & Billing References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Frequently Asked Questions

What is the difference between D23.1 and D23.0?

D23.1 is used for other benign neoplasms specifically located on the eyelid, while D23.0 is for benign neoplasms of the eyelid that are unspecified. D23.1 requires more detailed documentation regarding the type and characteristics of the neoplasm.